Neurocrine Biosciences, Inc. (LON:0K6R)

Neurocrine Biosciences Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	9,652	11,039	10,163	9,530	5,967	6,559
Market Cap Growth	-17.21%	8.62%	6.65%	59.70%	-9.03%	-12.25%
Enterprise Value	9,286	10,287	9,518	9,101	5,736	6,246
Last Close Price	95.99	108.92	104.04	98.59	63.33	70.46
PE Ratio	37.97	40.49	51.85	74.32	90.18	21.99
PS Ratio	5.27	5.87	6.86	7.71	7.13	8.56
PB Ratio	4.91	5.34	5.80	6.72	5.88	7.95
P/TBV Ratio	4.98	5.43	5.91	6.90	5.88	7.95
P/FCF Ratio	-	24.80	35.80	35.56	34.66	41.15
P/OCF Ratio	-	23.21	33.20	33.83	31.50	39.19
EV/Sales Ratio	4.90	5.47	6.43	7.37	6.85	8.15
EV/EBITDA Ratio	21.11	21.11	29.14	41.44	35.51	25.37
EV/EBIT Ratio	24.64	22.09	30.71	44.04	37.38	26.04
EV/FCF Ratio	24.06	23.11	33.53	33.96	33.32	39.19
Debt / Equity Ratio	0.18	0.19	0.19	0.15	0.32	0.37
Debt / EBITDA Ratio	0.84	0.76	0.99	0.94	1.88	1.19
Debt / FCF Ratio	0.93	0.89	1.19	0.81	1.89	1.90
Asset Turnover	0.70	0.68	0.67	0.67	0.60	0.69
Inventory Turnover	18.63	15.99	16.48	14.85	11.71	12.59
Quick Ratio	2.88	3.06	2.25	2.49	3.65	5.14
Current Ratio	3.20	3.40	2.45	2.70	3.96	5.45
Return on Equity (ROE)	13.39%	14.16%	12.68%	10.03%	7.17%	46.20%
Return on Assets (ROA)	8.67%	10.46%	8.78%	7.01%	6.82%	13.46%
Return on Capital (ROIC)	10.42%	12.68%	10.66%	8.22%	7.75%	15.33%
Return on Capital Employed (ROCE)	14.90%	18.20%	15.20%	13.60%	11.40%	21.20%
Earnings Yield	2.63%	2.47%	1.93%	1.35%	1.11%	4.55%
FCF Yield	4.00%	4.03%	2.79%	2.81%	2.89%	2.43%
Buyback Yield / Dilution	0.05%	-2.67%	-2.12%	-1.02%	-0.10%	-2.19%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.